Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001056520-14-000056
Filing Date
2014-04-15
Accepted
2014-04-15 13:10:13
Documents
9
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cellcyte201310kfinal.htm 10-K 543810
2 CERTIFICATION exhibit31.htm EX-31 12375
3 CERTIFICATION exhibit32.htm EX-32 5068
  Complete submission text file 0001056520-14-000056.txt   2426544

Data Files

Seq Description Document Type Size
4 INSTANCE ccyg-20131231.xml EX-101.INS 301257
5 SCHEMA ccyg-20131231.xsd EX-101.SCH 11395
6 CALCULATION ccyg-20131231_cal.xml EX-101.CAL 16013
7 DEFINITION ccyg-20131231_def.xml EX-101.DEF 23855
8 LABEL ccyg-20131231_lab.xml EX-101.LAB 130802
9 PRESENTATION ccyg-20131231_pre.xml EX-101.PRE 96970
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52238 | Film No.: 14764419
SIC: 2834 Pharmaceutical Preparations